{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:24:25Z","timestamp":1790918665074,"version":"4.1.0"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,12,17]],"date-time":"2004-12-17T00:00:00Z","timestamp":1103241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> To examine indicators of buprenorphine diversion and injection among injecting drug users in Melbourne, Australia and to determine the factors associated with buprenorphine injection.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Melbourne arm of the 2002 Illicit Drug Reporting System (IDRS) cross\u2010sectional study.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> Five Needle and Syringe Programme sites in Melbourne, Australia.<\/jats:p><jats:p><jats:bold>Participants\u2003<\/jats:bold> A total of 156 current injecting drug users (IDU). Study elibility criteria were at least monthly injection during the previous 6 months, and Melbourne residence for at least the preceding 12\u2003months.<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> Structured questionnaire covering demographic characteristics, drug use history, the price, purity and availability of drugs, criminal activity, risk\u2010taking behaviours, health\u2010related issues and general drug use trends.<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> Over one\u2010third (37%) of the study sample reported injecting buprenorphine in their life\u2010time and 33% reported injecting the drug in the last 6 months. Recent buprenorphine injection was associated with the injection of other drug types (i.e. polydrug injectors), opioid substitution treatment, injection\u2010related health problems and involvement in crime. Almost half (47%) of those who reported recent buprenorphine injection reported obtaining the drug illicitly at least once during that time.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Given the significant health harms associated with intravenous buprenorphine use (e.g. vein damage, abscesses and infections, precipitated withdrawal, blood\u2010borne virus transmission, hospitalization and death), routine monitoring of the misuse of buprenorphine in Melbourne is warranted. These results suggest the need for development of effective countermeasures to address diversion and injection of buprenorphine in this setting.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2004.00958.x","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T18:31:16Z","timestamp":1106937076000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?"],"prefix":"10.1111","volume":"100","author":[{"given":"Rebecca A.","family":"Jenkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig L.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Dobbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,1,28]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"418","article-title":"Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group","volume":"51","author":"Anonymous","year":"1993","journal-title":"Health Bulletin (Edinburgh)"},{"key":"e_1_2_6_3_1","first-page":"561","article-title":"Buprenorphine abuse in a group of 50 drug\u2010use abusers admitted to Marseille Hospital","volume":"47","author":"Arditti J.","year":"1992","journal-title":"Therapie"},{"key":"e_1_2_6_4_1","first-page":"95","article-title":"Abuse liability of buprenorphine\u2014a study among experienced drug users","volume":"42","author":"Bedi N. S.","year":"1998","journal-title":"Indian Journal of Physiology and Pharmacology"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00050-7"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00049-0"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-821X(05)80470-0"},{"key":"e_1_2_6_8_1","first-page":"28","article-title":"Assessment of buprenorphine in a drug discrimination procedure in humans","volume":"121","author":"Bigelow G. E.","year":"1992","journal-title":"NIDA Research Monograph"},{"key":"e_1_2_6_9_1","first-page":"106","volume-title":"Australian Drug Trends 2002","author":"Breen C.","year":"2003"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1990.tb01612.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595239300185751"},{"key":"e_1_2_6_12_1","first-page":"167","article-title":"Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose","volume":"176","author":"Clark N. C.","year":"2002","journal-title":"Medical Journal of Australia"},{"key":"e_1_2_6_13_1","volume-title":"National Pharmacotherapy Statistics Annual Data as at June 2002.","author":"Commonwealth Department of Health and Ageing","year":"2002"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07532.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230220119318"},{"key":"e_1_2_6_16_1","first-page":"1433","article-title":"Local complications after intravenous injection of dissolved tablets of buprenorphine","volume":"26","author":"Decocq G.","year":"1997","journal-title":"Presse Medicale"},{"key":"e_1_2_6_17_1","first-page":"7","volume-title":"The Course and Consequences of the Heroin Shortage in Victoria","author":"Dietze P.","year":"2003"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90092-5"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331979905000711"},{"key":"e_1_2_6_20_1","first-page":"1239","article-title":"Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?","volume":"25","author":"Gourarier L.","year":"1996","journal-title":"Presse Medicale"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1990.tb03088.x"},{"key":"e_1_2_6_22_1","first-page":"777","article-title":"Temgesic abuse","volume":"96","author":"Harper I.","year":"1983","journal-title":"New Zealand Medical Journal"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00293.x"},{"key":"e_1_2_6_24_1","first-page":"12","volume-title":"Victorian Drug Trends 2002: Findings from the Illicit Drug Reporting System (IDRS).","author":"Jenkinson R.","year":"2003"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","unstructured":"Johnson R. E. Chutuape M. A. Strain E. C. Walsh S. L. Stitzer M. L.&Bigelow G. E.(2000)A comparison of levomethadyl acetate buprenorphine and methadone for opioid dependence.New England Journal of Medicine 3431290\u20131297.","DOI":"10.1056\/NEJM200011023431802"},{"key":"e_1_2_6_26_1","first-page":"1350","article-title":"Assessment of opioid partial agonist activity with a three\u2010choice hydromorphone dose\u2010discrimination procedure","volume":"289","author":"Jones H. E.","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00454-6"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00215.x"},{"key":"e_1_2_6_29_1","volume-title":"National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Heroin Dependence.","author":"Lintzeris N.","year":"2001"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.94811757.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00335.x"},{"key":"e_1_2_6_32_1","volume-title":"The Cochrane Library","author":"Mattick R. P.","year":"2004"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230310001613994"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008236"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1988.tb00536.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96226710.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1984.tb108106.x"},{"key":"e_1_2_6_38_1","first-page":"72","article-title":"Abuse of buprenorphine","volume":"99","author":"Rainey H. B.","year":"1986","journal-title":"New Zealand Medical Journal"},{"key":"e_1_2_6_39_1","unstructured":"Ritter A. Kutin J. Lintzeris N.&Bammer G. eds (1997)Expanding treatment options for heroin dependence in Victoria: buprenorphine LAAM naltrexone and slow\u2010release oral morphine. New Pharmacotherapies Project Feasibility Report. Fitzroy Victoria:Turning Point Alcohol and Drug Centre Inc."},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90036-P"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00589.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02020.x"},{"key":"e_1_2_6_43_1","first-page":"645","article-title":"Prevalence of buprenorphine use by heroin addicts undergoing treatment","volume":"93","author":"San L.","year":"1989","journal-title":"Medicina Clinica (Barcelona)"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/0959523021000059848"},{"key":"e_1_2_6_45_1","first-page":"102","article-title":"Epidemiology of hepatitis C virus infection in Nepal","volume":"19","author":"Shrestha S. M.","year":"1998","journal-title":"Tropical Gastroenterology"},{"key":"e_1_2_6_46_1","first-page":"81","article-title":"Profile of drug addicts admitted to a hospital detoxification unit during a four\u2010and\u2010a\u2010half\u2010year period","volume":"20","author":"Sopelana P.","year":"1992","journal-title":"Actas Luso-Espanolas de Neurologia, Psiquiatria y Ciencias Afines"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000637"},{"key":"e_1_2_6_48_1","first-page":"628","article-title":"Buprenorphine effects in methadone\u2010maintained volunteers: effects at two hours after methadone","volume":"272","author":"Strain E. C.","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_49_1","first-page":"985","article-title":"Acute effects of buprenorphine, hydromorphone and naloxone in methadone\u2010maintained volunteers","volume":"261","author":"Strain E. C.","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050199"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92961-7"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9645978.x"},{"key":"e_1_2_6_53_1","first-page":"397","article-title":"Buprenorphine deviated from normal use: the buprenorphine injection","volume":"28","author":"Varescon I.","year":"2002","journal-title":"L\u2019Encephale"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00312-5"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00189-1"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.1.90"},{"key":"e_1_2_6_57_1","first-page":"328","article-title":"Acute hepatitis following intravenous buprenorphine injection as a substitute drug in a drug\u2010addict","volume":"25","author":"Wisniewski B.","year":"2001","journal-title":"Gastroenterologie Clinique and Biologique"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800831005"},{"key":"e_1_2_6_59_1","first-page":"1187","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers","volume":"282","author":"Zacny J. P.","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2004.00958.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2004.00958.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T03:38:10Z","timestamp":1698723490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2004.00958.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,28]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1360-0443.2004.00958.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00958.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,28]]},"assertion":[{"value":"2005-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}